Bharat Biotech’s typhoid vaccine gets WHO prequalification

Claimed to be the world’ s first conjugate typhoid vaccine, B ha rat B io te ch’ s Ty pb ar T CV has got p re qualified by World Health Organisation( ahead of a $85- million typhoid conjugate vaccine procurement plan. P re qualification by WHO comes as a significant breakthrough for the Hyderabad-based vaccinefew other countries since 2013 after working for over 11 years on its development.